Company / Cost of Revenue
Steris Cost of Revenue History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$2.9B
FY2026
5-year range
$1.7B / $3.1B
FY2022-FY2026
Trend
+14.3%
vs FY2025
Sector context
#24 of 113
Health Care
What the data says
Steris's cost of revenue of $2.9B is higher than 79% of companies in the Health Care sector (FY2026). Cost of Revenue has fluctuated over the past 10 years, ranging from $368M in FY2017 to $3.1B in FY2024.
Based on SEC 10-K filings.
$2.9B in FY2026 with a 5-year CAGR of +12.7%. Top quartile in the Health Care sector.
Improved from $3.1B to $2.9B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- +12.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 113This company $2.9B Sector average $11.3B
▼
-74.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.7%, indicating consistent growth.
- In FY2026, cost of revenue increased 14.3% year-over-year.
- Ranks #24 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.9B | +14.3% |
| FY2025 | $2.6B | -16.4% |
| FY2024 | $3.1B | +4.7% |
| FY2023 | $2.9B | +70.7% |
| FY2022 | $1.7B | +6.5% |
| FY2021 | $1.6B | -8.9% |
| FY2020 | $1.8B | +11.2% |
| FY2019 | $1.6B | -1.3% |
| FY2018 | $1.6B | +337.0% |
| FY2017 | $367.8M | -76.8% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026